✦ LIBER ✦

Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

✍ Scribed by Q. Li; J. Chalmers; S. Czernichow; B. Neal; B. A. Taylor; S. Zoungas; N. Poulter; M. Woodward; A. Patel; B. de Galan; G. D. Batty; on behalf of the ADVANCE Collaborative group

Publisher: Springer
Year: 2010
Tongue: English
Weight: 145 KB
Volume: 53
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-010-1862-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive function and risks of cardiova

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

✍ B. E. de Galan; S. Zoungas; J. Chalmers; C. Anderson; C. Dufouil; A. Pillai; M. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB

The Framingham and UK Prospective Diabet

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study

✍ A. P. Kengne; A. Patel; S. Colagiuri; S. Heller; P. Hamet; M. Marre; C. Y. Pan; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 217 KB